Livry Gargan, France

Patrick Fauveau

This inventor holds 25 USPTO granted patents, primarily in Antifungal Agents. Top assignees: Roussel Uclaf, Aventis Pharma S.a., Hoechst Marion Roussel. Active years: 1985-2007.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Patrick Fauveau. Retrieved from https://idiyas.com/inventor/patrick-fauveau

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 80.0

Average Co-Inventor Count = 3.8

ph-index = 4

Forward Citations = 46(Granted Patents)


Company Filing History:


Years Active: 1985-2007

Loading Chart...
Areas of Expertise:
Echinocandin Derivatives
Cephalosporins
Antifungal Agents
Preparation Process
Glutamic Acid Derivatives
Heterocyclic Dicarboxylic Acids
Dopaminergic Benzimidazol-2-ones
7-Hydroxy-Indoles
Pyrazolobenzoxazines
Aminopimelic Acids
25 patents (USPTO):Explore Patents

Title: A Spotlight on Patrick Fauveau: Innovator in Antifungal Agents

Introduction

Patrick Fauveau, a prominent inventor based in Livry Gargan, France, has made significant contributions to the field of pharmaceuticals, specifically in the development of antifungal agents. With an impressive portfolio of 25 patents, Fauveau has been at the forefront of innovation, aiming to improve therapeutic solutions and combat fungal infections.

Latest Patents

Fauveau's latest work includes notable patents like "Echinocandin derivatives, their method of preparation and their application as anti-fungal agents." This invention focuses on compounds that showcase antifungal properties, specifically those of formula (I), where substituents are meticulously defined for optimal efficacy. Another significant patent, "Derivatives of echinocandine, their preparation process and their use as antifungals," emphasizes the preparation process and the various isomer forms of the compounds that exhibit robust antifungal activity.

Career Highlights

Throughout his career, Fauveau has worked with leading pharmaceutical companies such as Roussel Uclaf and Aventis Pharma. His experiences at these organizations have paved the way for groundbreaking advancements within the pharmaceutical industry, particularly in antifungal research and development.

Collaborations

Patrick Fauveau's journey in innovation has been marked by fruitful collaborations with esteemed colleagues like Jozsef Aszodi and Jean-Francois Chantot. These partnerships have facilitated an exchange of ideas and expertise, enhancing the quality and impact of their collective research in the field of medicinal chemistry.

Conclusion

In summary, Patrick Fauveau stands out as a significant contributor to pharmaceutical innovations aimed at addressing fungal infections. Through his numerous patents and collaborations, he continues to shape the industry with his pioneering work, affirming his status as a key inventor in the realm of antifungal agents.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…